Seer (SEER) Revenue & Revenue Breakdown
Seer Revenue Highlights
Latest Revenue (Y)
$16.66M
Latest Revenue (Q)
$4.03M
Main Segment (Y)
Grant
Seer Revenue by Period
Seer Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $16.66M | 13.46% |
| 2022-12-31 | $14.69M | 129.67% |
| 2021-12-31 | $6.39M | 874.70% |
| 2020-12-31 | $656.00K | 1031.03% |
| 2019-12-31 | $58.00K | 100.00% |
| 2018-12-31 | - | - |
Seer generated $16.66M in revenue during NA 2023, up 13.46% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Seer Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $4.03M | 31.25% |
| 2024-06-30 | $3.07M | 0.20% |
| 2024-03-31 | $3.07M | -26.65% |
| 2023-12-31 | $4.18M | 9.60% |
| 2023-09-30 | $3.81M | 9.91% |
| 2023-06-30 | $3.47M | -6.67% |
| 2023-03-31 | $3.72M | -3.65% |
| 2022-12-31 | $3.86M | -2.43% |
| 2022-09-30 | $3.96M | 10.75% |
| 2022-06-30 | $3.57M | 8.28% |
| 2022-03-31 | $3.30M | 8.77% |
| 2021-12-31 | $3.03M | 41.35% |
| 2021-09-30 | $2.15M | 76.25% |
| 2021-06-30 | $1.22M | 1862.90% |
| 2021-03-31 | $62.00K | -81.55% |
| 2020-12-31 | $336.00K | 366.67% |
| 2020-09-30 | $72.00K | 1.41% |
| 2020-06-30 | $71.00K | -59.89% |
| 2020-03-31 | $177.00K | 205.17% |
| 2019-12-31 | $58.00K | - |
Seer generated $4.03M in revenue during Q3 2024, up 31.25% compared to the previous quarter, and up 116.20% compared to the same period a year ago.
Seer Revenue Breakdown
Seer Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| Grant | $1.10M | $223.00K | - |
| Service | - | $913.00K | $500.00K |
| Related Party | - | $5.21M | $2.32M |
| Grant and Other | - | $808.00K | - |
| Product | - | $8.56M | $3.58M |
Latest
Seer's latest annual revenue breakdown by segment (product or service), as of Dec 23: Grant (100.00%).
Quarterly Revenue by Product
| Product/Service | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Grant | $400.00K | $200.00K | $500.00K | $50.00K | $14.00K | $34.00K | $10.00K | $117.00K | $100.00K | - | - | - |
| Related Party | - | - | - | $1.31M | $1.72M | $1.32M | $1.11M | $1.07M | $1.15M | $787.00K | $380.00K | - |
| Grant and Other | - | - | - | $335.00K | - | - | - | - | - | - | - | - |
| Product | - | - | - | $2.34M | $1.43M | $2.57M | $2.41M | $2.15M | $1.88M | $858.00K | $837.00K | - |
| Service | - | - | - | $69.00K | $709.00K | $68.00K | $57.00K | $79.00K | $500.00K | - | - | - |
| Research and Development Activties | - | - | - | - | - | - | - | - | - | - | - | $300.00K |
Latest
Seer's latest quarterly revenue breakdown by segment (product or service), as of Dec 23: Grant (100.00%).
Seer Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| KYMR | Kymera Therapeutics | $78.59M | $3.74M |
| NRIX | Nurix Therapeutics | $76.99M | $12.59M |
| FHTX | Foghorn Therapeutics | $34.16M | $7.81M |
| SEER | Seer | $16.66M | $4.03M |
| MOLN | Molecular Partners | $7.04M | $2.74M |
| GBIO | Generation Bio | $5.90M | $4.09M |
| HCWB | HCW Biologics | $2.84M | $426.42K |
| STTK | Shattuck Labs | $1.66M | $1.61M |
| QSI | Quantum-Si | $1.08M | $787.00K |
| MNOV | MediciNova | $1.00M | - |
| LYEL | Lyell Immunopharma | $130.00K | $34.00K |
| ANEB | Anebulo Pharmaceuticals | - | - |
| CGEM | Cullinan Oncology | - | - |
| CCCC | C4 Therapeutics | - | - |
| ANTX | AN2 Therapeutics | - | - |
| PHVS | Pharvaris | - | - |
| NKTX | Nkarta | - | - |
| MLYS | Mineralys Therapeutics | - | - |
| ORIC | ORIC Pharmaceuticals | - | - |
| SANA | Sana Bio | - | - |
| GLUE | Monte Rosa Therapeutics | - | $4.70M |
| PEPG | PepGen | - | - |